Improved respiratory system conductance following bronchodilator predicts reduced exertional dyspnoea

被引:15
作者
Diba, Chantale [1 ,2 ]
King, Gregory G. [1 ,2 ,3 ,4 ]
Berend, Norbert [1 ,2 ,4 ]
Salome, Cheryl M. [1 ,2 ]
机构
[1] Woolcock Inst Med Res, Sydney, NSW 2050, Australia
[2] Univ Sydney, Sydney, NSW 2006, Australia
[3] Royal N Shore Hosp, Dept Resp Med, St Leonards, NSW 2065, Australia
[4] Cooperat Res Ctr Asthma & Airways, Camperdown, NSW 2050, Australia
关键词
Chronic obstructive pulmonary disease; Forced oscillation technique; Bronchoditator; Six-minute walk test; Airway calibre; OBSTRUCTIVE PULMONARY-DISEASE; FORCED OSCILLATION TECHNIQUE; EXPIRATORY FLOW LIMITATION; 6-MINUTE WALK TEST; EXERCISE PERFORMANCE; LUNG HYPERINFLATION; AIRWAY-OBSTRUCTION; DYNAMIC HYPERINFLATION; COPD; BREATHLESSNESS;
D O I
10.1016/j.rmed.2011.03.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: In COPD, improvements in lung mechanics following bronchodilator, measured using the forced oscillation technique (FOT), are more sensitive than spirometry at detecting improvement in lung function following bronchodilator. The relationship between these improvements in lung mechanics and improvements in functional outcomes, such as exertional dyspnoea, following bronchodilator, in COPD is unknown. Methods: 17 COPD subjects were recruited into a double blind placebo controlled randomised cross over study. Dyspnoea was induced using a standardised six-minute walk test (6 MWT), and measured by borg score throughout the test. Measurement of respiratory system conductance (Grs), respiratory system reactance (Xrs), inspiratory capacity (IC) and spirometry were made at baseline and 1 h after a single dose of either 18 mu g of tiotropium bromide plus 200 mu g salbutamol, or placebo. Results: Subjects had a mean baseline FEV(1) of 45.5 +/- 11.0% predicted. The bronchodilator induced reduction in exertional dyspnoea correlated significantly with the increase in Grs (r(s) = 0.59, p = 0.01) and approached significance with FEV(1) (r(s) = 0.45, p = 0.07) but not with FVC (r(s) = 0.30, p = 0.24), Xrs (r(s) = 0.19, p = 0.47) or IC (r(s) = -0.08, p = 0.78). Increase in Grs was the best and sole predictor of reduction in exertional dyspnoea, explaining 41% of the variance. There was no additional contribution to the model from the increase in FEV(1) or IC. Conclusion: Bronchodilator induced improvements in exertional dyspnoea in moderate to severe COPD are predicted by improvements in Grs, measured by FOT, independent of improvements in spirometry or hyperinflation. The findings suggest that FOT may be useful for measuring response to bronchodilator in COPD. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1345 / 1351
页数:7
相关论文
共 49 条
  • [1] Effect of salbutamol on lung function and chest wall volumes at rest and during exercise in COPD
    Aliverti, A
    Rodger, K
    Dellacà, RL
    Stevenson, N
    Lo Mauro, A
    Pedotti, A
    Calverley, PMA
    [J]. THORAX, 2005, 60 (11) : 916 - 924
  • [2] [Anonymous], RESP MED SB
  • [3] Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease
    Belman, MJ
    Botnick, WC
    Shin, JW
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 153 (03) : 967 - 975
  • [4] Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1177/096228029900800204
  • [5] Volume effect and exertional dyspnoea after bronchodilator in patients with COPD with and without expiratory flow limitation at rest
    Boni, E
    Corda, L
    Franchini, D
    Chiroli, P
    Damiani, GP
    Pini, L
    Grassi, V
    Tantucci, C
    [J]. THORAX, 2002, 57 (06) : 528 - 532
  • [6] Measuring bronchodilation in COPD clinical trials
    Borrill, ZL
    Houghton, CM
    Woodcock, AA
    Vestbo, J
    Singh, D
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 59 (04) : 379 - 384
  • [7] The use of plethysmography and oscillometry to compare long-acting bronchodilators in patients with COPD
    Borrill, Zoe L.
    Houghton, Catherine M.
    Tal-Singer, Ruth
    Vessey, S. Rupert
    Faiferman, Isidore
    Langley, Stephen J.
    Singh, Dave
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 65 (02) : 244 - 252
  • [8] BROCHARD L, 1987, AM REV RESPIR DIS, V135, P579
  • [9] Reference equations for respiratory system resistance and reactance in adults
    Brown, Nathan J.
    Xuan, Wei
    Salome, Cheryl M.
    Berend, Norbert
    Hunter, Michael L.
    Musk, A. W.
    James, Alan L.
    King, Gregory G.
    [J]. RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY, 2010, 172 (03) : 162 - 168
  • [10] A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease
    Casaburi, R
    Mahler, DA
    Jones, PW
    Wanner, A
    San Pedro, G
    ZuWallack, RL
    Menjoge, SS
    Serby, CW
    Witek, T
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2002, 19 (02) : 217 - 224